Weekly injections lose more weight on average. Daily tablets are easier to live with. Neither fact alone should make the decision — here's how the trade-offs actually stack up, without the marketing spin.
Reviewed by Orali · Clinical Lead — a GPhC-registered Pharmacist Independent Prescriber · Last updated 12 June 2026
| Weekly injections | Daily tablets | |
|---|---|---|
| Average weight loss in trials | ~15–20%+ over 68–72 weeks | ~3–17% depending on the medicine |
| Routine | One self-injection a week | One tablet a day; some need fasting rules, the newest don't |
| Needles | Yes — fine, short, pre-filled pens | None |
| Storage | Some need refrigeration | Room temperature |
| Travel | Needs a little planning | Goes in a pocket |
| Side effects | Broadly the same for the GLP-1 class: nausea, constipation, vomiting, diarrhoea — usually mild to moderate, worst around dose increases | |
| UK availability | Available now via prescription | Some available now; new oral GLP-1s expected from late 2026 |
Trial figures are averages from separate studies with different designs and populations — a guide, not a head-to-head comparison. Individual results vary. All of these are prescription-only medicines requiring a clinical assessment.
The strongest average results in trials so far belong to the weekly injections — around 15–20%+ body weight loss over 68–72 weeks. The best current and emerging tablets reach roughly 12–17% in their own trials. That gap is real, but so is this: the medicine you take consistently beats the medicine you abandon.
No needles, no sharps bin, no refrigeration, nothing to explain at airport security. Older oral options come with strict fasting rules; the newest generation has none. If the weekly injection ritual is the thing you dread, a daily tablet that disappears into your morning may be the difference between sticking with treatment and quietly stopping.
Tablet or injection, GLP-1 medicines share the same gut-hormone pathway, so the side effect profile is similar: nausea, constipation, vomiting and fatigue, mostly during dose increases. The practical difference is dosing flexibility — your prescriber can fine-tune either route. Read our side effect management guide for what helps.
Private treatment pricing depends on the medicine and dose, not just the format. Tablets are cheaper to manufacture at scale, which may bring prices down as new oral options launch — but no UK price for the newest pill has been announced. We've covered what's known about UK pricing here.
There's no universally right answer — there's the right answer for you. That's not a cop-out; it's the reason a consultation exists. We'll lay the options out plainly, and the decision stays yours.
On average, yes — the leading weekly injections produced around 15–20%+ average body weight loss in trials, against roughly 3–17% for tablets depending on the medicine. But these come from separate studies, not head-to-head trials, and the spread between individuals on the same medicine is bigger than the gap between the averages. Consistency and tolerability decide your result more than the format does.
Not inherently. The GLP-1 tablets and injections share the same mechanism, so the core side effect profile is similar. "Safer for you" depends on your health history, other medicines and how you respond — which is exactly what the clinical assessment is for.
Sometimes, under prescriber supervision. Switching depends on the specific medicines, your progress, and why you want to change. It's a clinical decision with dosing implications — never a straight swap, and never something to do on your own.
No. The new oral GLP-1s are a genuinely useful addition, but on current evidence the injections still lead on average weight loss. Expect both to coexist: tablets for people who value simplicity, injections where maximum effect matters most. Our orforglipron tracker follows the newest pill's path to the UK.
The free eligibility check takes three minutes and tells you where you stand. If treatment looks right, a consultation with a pharmacist prescriber settles the pill-or-injection question for your circumstances — not the average person's.
Start the free eligibility checkA consultation never guarantees a prescription — if treatment isn't right for you, we'll say so.